Completed PHASE4 INTERVENTIONAL 2-arm NCT01748279

The Effects of Atorvastatin Treatment in COPD Patients

Sponsor: Medical University of Bialystok

Conditions COPD

Interventions Atorvastatin Formoterol Lactose tablet

Updated 5 times since 2017 Last updated: Apr 21, 2013 Started: Dec 31, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01748279, this PHASE4 trial focuses on COPD and remains completed. Sponsored by Medical University of Bialystok, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Bialystok

Data source: Medical University of Bialystok

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bialystok, Poland